Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Home > Insider Trading > M Franklin Berger > Profile

M Franklin Berger

Affiliations

Director at Proteostasis Therapeutics Inc. (PTI), 2019-07-01
Director at Kezar Life Sciences Inc. (KZR), 2019-06-27
Director at Atreca Inc. (BCEL), 2019-06-24
Director at Five Prime Therapeutics Inc (FPRX), 2019-06-12
Director at Tocagen Inc (TOCA), 2019-05-31
Director at Immune Design Corp. (IMDZ), 2019-04-04
Director at Seattle Genetics Inc (SGEN), 2014-02-25
Director at Asterias Biotherapeutics Inc. (NONE), 2013-09-28
Director at Biotime Inc (BTX), 2013-08-22

Insider Trading: Purchases See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Proteostasis Therapeutics Inc.	PTI	$6.75	40,000	Director	40,000	2018-10-26	Filing
Kezar Life Sciences Inc.	KZR	$15.00	50,000	Director	563,157	2018-06-25	Filing
Proteostasis Therapeutics Inc.	PTI	$5.00	60,000	Director	266,162	2017-12-18	Filing
Immune Design Corp.	IMDZ	$4.58	25,000	Director	75,000	2017-10-30	Filing
Immune Design Corp.	IMDZ	$4.26	25,000	Director	50,000	2017-10-25	Filing

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Immune Design Corp.	IMDZ	$6.55	50,000	Director	25,000	2016-12-16	Filing